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On subcellular fractionation, the enzyme acyl/alkyl dihydroxyacetone phosphate 
(DHAP) reductase (EC 1.1.1.101) in guinea pig and rat liver was found to be present in 
both the light mitochondrial (L) and microsomal fractions. By using metrizamide density 
gradient centrifugation, it was shown that the alkyl DHAP reductase activity in the 
“L” fraction is localized mainly in peroxisomes. From the distribution of the marker 
enzymes it was calculated that about two-thirds of the liver reductase activity is in the 
peroxisomes and the rest in the microsomes. The properties of this enzyme in peroxisomes 
and microsomes are similar with respect to heat inactivation, pH optima, sensitivity to 
trypsin, and inhibition by NADP+ and acyl CoA. The enzyme activity in the peroxisomes 
and microsomes from mouse liver is increased to the same extent by chronically feeding 
the animals clofibrate, a hypolipidemic drug. The kinetic properties of this enzyme in 
these two different organelles are also similar. From these results it is concluded that 
the same enzyme is present in two different subcellular compartments of liver. o 19% 
Academic Press, Inc. 
Acyl dihydroxyacetone phosphate (acyl 
DHAP2) pathway is important for the bio- 
synthesis of glycerolipids, especially glyc- 
erol ether lipids (l-3). Acyl DHAP and its 
ether analog, alkyl DHAP, are enzymati- 
tally reduced by NADPH to form the cor- 
responding sn-glycerol3-phosphate deriv- 
atives (4-6). The reductions of both acyl 
DHAP and alkyl DHAP are probably cat- 
alyzed by the same enzyme, i.e., acyl/alkyl 
DHAP reductase (EC 1.1.1.101) (6-8). Pre- 
viously it was shown that this enzyme is 
present in all mammalian tissues analyzed 
and it is localized in the microsomal and 
mitochondrial fractions of these tissues (6). 
However, the recent demonstration that in 
’ This work was supported by Grants NS-08841 and 
NS-15747 from the U. S. Public Health Service, Na- 
tional Institutes of Health. 
‘Abbreviations used: DHAP, dihydroxyacetone 
phosphate; G-3-P, sn-glycerol 3-phosphate; DTT, di- 
thiothreitol. 
rodent livers DHAP acyltransferase, the 
first enzyme of this pathway, is mainly lo- 
calized in the peroxisomes (9) suggests that 
the reductase may also be localized in per- 
oxisomes and not in mitochondria. Prelim- 
inary evidence indicated that the reductase 
is indeed present in the peroxisomal frac- 
tion of liver (9); however, compared to the 
DHAP acyltransferase, relatively more 
reductase activity was found to be present 
in the microsomal fraction. This nonper- 
oxisomal localization of the reductase is 
also evidenced by the finding that although 
DHAP acyltransferase is absent in the 
cultured skin fibroblasts and leukocytes of 
Zellweger cerebrohepatorenal syndrome 
patients (who lack peroxisomes), the re- 
ductase activity is almost normal (10). This 
dual distribution naturally raises the 
question of whether or not the same en- 
zyme is present in both peroxisomes and 
endoplasmic reticulum. Therefore, the 
subcellular distribution and the properties 
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of the reductase in different fractions of 
rodent livers and its induction by the ad- 
ministration of clofibrate to the animals 
were studied in detail. The results of these 
studies are presented here. 
MATERIALS AND METHODS 
NADPH, NADH, NADP+, palmitoyl CoA, DHAP, 
G-3-P, cytochrome c, D-ghCOSe B-phosphate, and @- 
glycerophosphate were obtained from Sigma Chemical 
Company (St. Louis, MO.). Fatty acid poor bovine 
serum albumin was obtained from Miles Laboratories 
(Elkhart, Ind.). Metrizamide (analytical grade) was 
obtained from Accurate Chemical Co. (Westbury, 
N. Y.). 
B-[4-‘HjNADPH was prepared from Djl-%]ghcose 
and purified by DEAE-Sephacel chromatography as 
described (11). Aliquots of the purified [8HjNADPH 
eluted with the NaCl gradient were lyophilized and 
stored at room temperature in the dark under vacuum 
over Drierite. NADPH stored under such conditions 
was found to remain stable for several months. Before 
use, the dry [8HjNADPH was dissolved in water and 
nonradioactive NADPH was added to make the de- 
sired specific activity (usually 5000 cpm/nmol) and 
the solution was stored at 4°C for not more than 2-3 
days. [82PlDHAP and [8lP]G-3-P were prepared by the 
enzymatic phosphorylation of dihydroxyacetone and 
glycerol, respectively, and purified by the barium salt 
precipitation method as described previously (12). l- 
O-Hexadecyl DHAP and palmitoyl DHAP were syn- 
thesized by phosphorolysis of the corresponding di- 
azoacetones (13). 
The subcellular fractionation of guinea pig liver was 
done according to de Duve and co-workers (14) with 
slight modifications as described previously (15). Five 
fractions, i.e., nuclear (sedimenting at 6OOOg.&, mi- 
tochondrial (33,OOOg,i”), light mitochondrial 
(25O,OOOg,,&, microsomal(6 X 106gmin), and cytosol(>6 
X 106Qmi,), were stored in 0.25 Y sucrose at -20°C in 
small aliquots. The fractions were rapidly thawed be- 
fore use and were not reused. The liver postnuclear 
supernatant was also fractionated in linear metri- 
zamide density gradient (205O%)centrifugation using 
a vertical rotor as described elsewhere (16). Metri- 
zamide density gradient centrifugation (16) was also 
used to prepare peroxisomes from guinea pig liver 
light mitochondrial fraction. 
Acyl/alkyl DHAP reductase was assayed by mea- 
suring the formation of labeled lipid from hexadecyl 
DHAP and B-[4-8HlNADPH. An emulsion of hexa- 
decyl DHAP (or palmitoyl DHAP when necessary) 
was made by sonicating 1.0 pmol of lipid with 2 mg 
of Tween 20 in 0.5 ml of 50 mM Tris-HCl buffer (pH 
7.5). An aliquot (generally 0.05 ml) of the emulsion 
was added to the incubation mixture. The final assay 
mixture contained 33.3 mM potassium phosphate 
buffer (pH 6.5), NaF (10 mM), EDTA (0.66 ml@, Tris- 
HCl(4 mM), Tween 20 (0.2 mg), hexadecyl DHAP (0.1 
rmol), B-[4-‘HINADPH (67 PM, 5 X lo6 cpm/pmol), 
and enzyme in a total volume of 0.6 ml. After 15 min 
incubation at 37”C, the labeled lipid formed was ex- 
tracted and washed under acidic conditions and the 
radioactivity was determined as described before (6). 
The following marker enzymes were assayed by the 
published procedures as indicated: catalase (17), acid 
phosphatase (18, 19), succinate-cytochrome c reduc- 
tase (20), glucose-6-phosphatase (21), and lactate de- 
hydrogenase (22). DHAP acyltransferase and G-3-P 
acyltransferase were assayed by measuring the for- 
mation of radioactive lipid from either [=P)DHAP or 
$P]G-3-P as described previously (23). Protein was 
determined by Lowry’s method using bovine serum 
albumin as a standard (24). When interfering sub- 
stances such as metrizamide were present, the protein 
was first coprecipitated with deoxycholic acid (25) be- 
fore using Lowry’s method. 
For the administration of clofibrate, groups of mice 
(three in each group, 30-32 g each) were fed, ad libitum, 
powdered food containing clofibrate (0.5% w/w). The 
control mice were fed only the powdered food. The 
livers of the mice in each group were pooled together, 
homogenized, and fractionated by differential cen- 
trifugation as described above. 
All other methods are the same as previously de- 
scribed (6, 9, 12). 
RESULTS 
Subcellular Distribution of AcyVAlkyl 
DHAP Reductase 
The distribution of the reductase in the 
guinea pig liver subcellular fraction shows 
that this enzyme is enriched in the “light 
mitochondrial” and microsomal fractions 
(Fig. 1). In terms of total activity, the en- 
zyme is found to be distributed in the mi- 
tochondrial(25% of total), light mitochon- 
drial (35%), and microsomal (35%) frac- 
tions. In contrast, the distribution of 
DHAP acyltransferase, the first enzyme of 
this pathway, is 27% in the mitochondrial 
fraction, 59% in light mitochondrial, and 
14% in the microsomes. 
That most of the reductase activity 
present in the “light mitochondrial” frac- 
tion is indeed peroxisomal is shown by 
fractionating the “L” fraction by centrif- 
ugation through a metrizamide density 
gradient. In this gradient the peroxisomes 
are well separated from other organelles 
(16) and the reductase activity was found 
ACYL/ALKYL DIHYDROXYACETONE PHOSPHATE REDUCTASE 
CUMULATIVE % PROTEIN 
FIG. 1. Distribution pattern of acyl/alkyl DHAP reductase and other marker enzymes in guinea 
pig liver subcellular fractions. Relative specific activity with respect to that of homogenate is plotted 
against the percentage of total protein according to de Duve et al (14). The fractions are represented 
according to the order in which they are isolated, i.e., from left to right: (A) nuclear fraction, (B) 
mitochondrial fraction, (C) light mitochondrial fraction (“L” fraction), (D) microsomal fraction, 
(E) cytosol. The enzymes are assayed as described in the text. The specific activities of different 
enzymes in the homogenate are (a) catalase, 291.1 units/mg protein; (b) G-3-P acyltransferase (GPAT), 
0.47 nmol/min/mg, (c) acyl/alkyl DHAP reductase, 9.27 nmol/min/mg protein; (d) acid phosphatase, 
9.02 nmol/min/mg protein; (e) DHAP acyltransferase (DHAPAT), 0.36 nmol/min/mg protein; (f) 
glucose-6-phosphatase, 63.4 nmol/min/mg protein; (g) succinate-cytochrome c reductase, 35 units/ 
mg protein; (h) lactic dehydrogenase, 0.208 kmol/min/mg protein. 
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to be associated mostly with the peroxi- 
somal fractions (data not shown; however, 
see Fig. 2). In rat liver the reductase activ- 
ity is also found to be present in both per- 
oxisomes and microsomes. This is shown 
in Fig. 2 where the liver homogenate (mi- 
nus the nuclear fraction) was subjected to 
a metrizamide density gradient centrifu- 
gation procedure. A portion of the reduc- 
tase is seen to be sedimented with the 
DHAP acyltransferase and catalase indi- 
cating the peroxisomal localization of the 
reductase. About 58% of the reductase 
seems to be extraperoxisomal compared 
to only 33% of DHAP acyltransferase 
(Fig. 2). 
Properties of the Peroxisomal and 
Microsomal Acyl/Alkyl DHAP 
Reductase 
The properties of the reductase in the 
guinea pig liver peroxisomal fraction and 
the microsomal fraction are studied in de- 
tail. It should be noted that though the 
peroxisomes used did not contain any glu- 
case-6-phosphatase activity (microsomal 
marker enzyme), the microsomal fraction 
contained 10-12’S of the total cellular sed- 
imentable catalase (marker enzyme for 
peroxisomes and microperoxisomes). 
(a) pH optima. The activity of both the 
peroxisomal and microsomal enzymes was 
measured from pH 4.5 to pH 9.0 and the 
highest activity in both cases was found at 
pH 6.5 with a broad shoulder of activity up 
to pH 8.5. The activity is not influenced by 
buffer composition as fairly continuous pH- 
versus-enzyme activity curves were ob- 
tained even though different buffers were 
used (Fig. 3A). 
(6) Heat stability. Both the peroxisomal 
and microsomal reductases are fairly heat 
stable. As shown in Fig. 3B heating the en- 
zyme at 5O”C, or even at 55”C, for 15 min 
did not diminish much of their activities. 
The heat stability of this enzyme in both 
these subcellular organelles is enhanced in 
the presence of the cosubstrate NADPH 
(Fig. 3B). 
(c) Lability toward trypsin, Proteolytic 
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FIG. 2. Distribution of acyl/alkyl DHAP reductase 
with postnuclear supernatant of normal rat liver after 
centrifugation in a linear metrizamide gradient. The 
particles from the liver homogenate of rat liver were 
pelleted at 600~ for 10 min and the postnuclear su- 
pernatant was applied to 20-50% linear metrizamide 
gradient centrifugation as described elsewhere (16). 
Percentages of total activity are plotted against each 
fraction. 
been extensively used to study the topog- 
raphy of enzymes in vesicular membranes 
(26,27). When such experiments were done 
using the peroxisomal and microsomal 
fractions, it was found that the reductase 
in both the organelles is extremely labile 
toward treatment with trypsin in the pres- 
ence or absence of the detergent Triton X- 
100 (Fig. 3C). The enzyme remained stable 
when treated with Triton alone or when 
the trypsin was immediately neutralized 
by the addition of antitrypsin (Fig. 3C). 
(a?) Other properties. Both the peroxi- 
somal and microsomal reductases are sta- 
ble toward high concentrations (up to 10 
mM) of sulfhydryl group inhibitors such as 
N-ethylmaleimide and DTNB. Thiols such 
as DTT do not have any effect on the mem- 
brane-bound enzymes but these agents in- 
crease the stability of the enzymes after 
solubilization from membranes. NADP+, a 
product, inhibits both the peroxisomal and 
microsomal enzymes (see later). As de- 
scribed by Coleman and Bell (28), it was 
found that palmitoyl CoA at low concen- 
tration (10 pM) inhibited both the micro- 
somal and peroxisomal enzyme to the same 
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FIG. 3. (A) Effect of pH on the activity of acyl/alkyl 
DHAP reductase. The activity of both peroxisomal 
and microsomal enzymes was determined at different 
pH values. Different buffers (0.5M) were used to dif- 
ferent pH values: acetate buffers from pH 4.5 to 5.5; 
potassium phosphate buffer from pH 6.0 to 7.5 range; 
Tris-HCl buffer from pH 8.0 to 9.5. Results are ex- 
pressed in percent of maximum activity which are ‘72 
nmol/min/mg for peroxisomes and 14.1 nmol/min/ 
mg for microsome. (B) Effect of heat on the enzymatic 
reduction of alkyl DHAP by microsomal and peroxi- 
somal DHAP reductase. Samples of peroxisomes and 
microsomes were heated for 15 min at different tem- 
peratures in the absence (-) and presence (- - -) of 
0.2 mru NADPH followed by rapid cooling in ice water. 
The aliquots were assayed for reductase activity at 
37°C as described in the text. (C) Effect of trypsin 
treatment on peroxisomal and microsomal acyl/alkyl 
DHAP reductase. Peroxisomes (0.36 mg protein) and 
microsomes (0.18 mg protein) were incubated at room 
temperature in the presence of [A] buffer (10 mM Tris- 
HCl, pH 7.4, in 0.25 M sucrose), [B] 0.05% Triton X- 
100 in buffer, [C] trypsin inactivated with soybean 
trypsin inhibitor, [D] trypsin (0.02 mg) together with 
Triton, and [E] trypsin (0.02 mg) alone. After 10 min 
incubation at room temperature, trypsin inhibitor (0.2 
mg) was added to [D] and [E] to stop the trypsin 
digestion. DHAP acyltransferase and acyl/alkyl 
DHAP reductase activity were determined in aliquots 
of these samples. The values are expressed as per- 
centages of activity relative to the control (82 nmol/ 
min/mg protein for peroxisomes and 15 nmol/min/ 
mg protein for microsomes). 
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extent (‘75%). The enzymes from both the 
subcellular organelles can be solubilized 
with detergents in the presence of high 
concentration of salt (KCl) and the solu- 
bilized enzyme(s) is stabilized by the ad- 
dition of the cosubstrate NADPH [Ref. (7) 
and also Ghosh and Hajra (unpublished 
experiments)]. 
Kinetic Properties 
Both the peroxisomal and microsomal 
reductases follow regular Michaelis-Men- 
ten kinetics when the NADPH concentra- 
tions are varied keeping the concentrations 
of alkyl DHAP and acyl DHAP a constant. 
The Km and V,, values obtained from such 
experiments are given in Table I. As de- 
scribed previously (6, 29), NADH at high 
concentrations can also be utilized by the 
enzyme to reduce acyl DHAP or alkyl 
DHAP. The kinetic constants obtained by 
using NADH as a cosubstrate are given in 
Table I. Hyperbolic curves were also ob- 
tained when NADPH concentration was 
kept constant (66 PM) varying the concen- 
trations of alkyl DHAP. However, in this 
case at high concentrations of alkyl DHAP 
deviations from linearity (reciprocal plot) 
were observed probably because of the in- 
hibition of the enzyme by high concentra- 
tions of alkyl DHAP. The apparent Km of 
alkyl DHAP is given in Table I. 
NADP+ acts as a competitive inhibitor 
of NADPH for both the peroxisomal and 
microsomal enzymes. As shown in Fig. 4, 
the apparent Km values of the enzymes for 
NADPH are increased in the presence of 
NADP+. The Ki values for NADP+ calcu- 
lated from these results are 2.1 pM for the 
peroxisomal and 1.8 pM for the microsomal 
enzyme. 
Efect of Feeding Clojibrate 
A number of hypolipidemic drugs when 
fed to rodents cause a proliferation of per- 
oxisomes in liver and induce a number of 
peroxisomal and microsomal enzymes (30, 
31). When mice were chronically fed clofi- 
brate, a hypolipidemic drug, for 7 days an 
increase of 55-70s of the total liver acyl/ 
alkyl DHAP reductase was observed. As 
described previously (31), the liver DHAP 
acyltransferase activity in these animals 
was increased by lOO-120% and the cata- 
lase activity by 50-70s. The distribution 
of the reductase between the peroxisomes 
and microsomes in mouse liver is similar 
to those found in guinea pig and rat liver. 
The increase in activity of the reductase 
after clofibrate administration is found to 
TABLE I 
KINETIC CONSTANTS FOR SUBSTRATES AND COSUBSTRATES OF ALKn DHAP REDUCTASE 
Peroxisomes Microsomes 
NADPH’ 
NADPH’ (in presence of 
100 phi NADP +) 
NADHa 
































Note. Values were obtained from double-reciprocal plots of rate vs substrate concentrations. The best-fit 
line was drawn through all the points and values were obtained using one enzyme preparation for all the 
experiments. 
’ O-Hexadecyl DHAP (170 pt~) was used as the substrate, 
b NADPH concentration was 66 PM. 
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FIG. 4. Effect of increasing concentration of NADPH on the rate of acyl/alkyl DHAP reductase 
activity in the presence and absence of NADP+. The assays were carried out as described under 
Materials and Methods using alkyl DHAP (170 FM) as substrate and varying concentrations (O-133 
PM) of NADPH and a fixed concentration (100 PM) of NADP+ in a total volume of 0.6 ml. 
be similar (160% of the control) in both the 
microsomal and peroxisomal fractions 
(Table II). A single time-course experiment 
indicates that there was an equal rate of 
increase in the activity of the enzyme in 
microsomal and peroxisomal fractions 
from Day 1 to Day 5 after which the activ- 
ities reached a plateau of 170% of normal 
controls. 
DISCUSSION 
Results presented here indicate that the 
acyl/alkyl DHAP reductase has a dual 
subcellular distribution in liver. If it is as- 
sumed that particulate-bound catalase is 
the marker enzyme for peroxisomes and 
glucose-6-phosphatase is the marker en- 
zyme for microsomes, then it can be cal- 
culated from the data presented in Figs. 1 
and 2 that 65-70s of the reductase is in 
peroxisomes and 30-35s in microsomes. 
However, these estimates may not be ac- 
curate because the microsomal fraction 
may contain membrane fragments of per- 
oxisomes which contains no catalase and 
also the microperoxisomes with unknown 
amounts of catalase. In this respect mem- 
brane-bound DHAP acyltransferase prob- 
ably would be a better marker enzyme for 
peroxisomes and microperoxisomes. In 
comparison to the DHAP acyltransferase, 
the liver microsomal fraction contains 20- 
25% more of acyl/alkyl DHAP reductase. 
In both peroxisomes and microsomes the 
reductase activity was lost after a brief 
TABLE II 
EFFECT OF CLOFIBRATE ADMINISTRATION ON MOUSE 














Note A group of mice (3 in group) were fed powdered 
food either mixed with clofibrate (0.5 g/100 g food, 
average intake of clofibrate = 23 mg/day) or without 
clofibrate (control) for ‘7 days. They were sacrificed 
and acyl/alkyl DHAP reductase activity in total ho- 
mogenate, postnuclear supernatant, light mitochon- 
drial (L), and microsomal fractions of liver were de- 
termined as described in the text. 
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trypsin treatment, indicating that the en- 
zyme is exposed to the cytosolic side of the 
membrane. This is in contrast to the to- 
pography of DHAP acyltransferase which, 
from a similar kind of experiment, is pos- 
tulated to be present in the luminal side of 
the peroxisomal and microsomal vesicles 
membranes (27,32). This indicates that the 
acyl DHAP synthesized inside the peroxi- 
somes is transported out and is reduced by 
the cytosolic NADPH. Therefore, our pre- 
vious assumption (33) that in the acyl 
DHAP pathway the 3H from D-[~-~H]- or 
D-[3-3H]glucose is incorporated via 
NADPH at the C-2 position of glycerolipid 
appears to be valid. 
Besides the topological similarities, both 
the microsomal and the peroxisomal en- 
zymes have similar properties with respect 
to the pH optimum, heat stability, sub- 
strate specificity, inhibition by NADP+, 
and kinetic properties. Therefore, it may 
be concluded that the same enzyme is 
present in both these organelles. The minor 
quantitative differences in the kinetic con- 
stants of the enzyme in peroxisomes and 
microsomes (Table I) may be due to the 
different environment of the enzyme in 
these two different membranes. Not many 
enzymes common to these two organelles 
are described in the literature. The only 
other example is carnitine acetyltransfer- 
ase which has been well studied by Bieber, 
Tolbert, and co-workers (34, 35). Though 
carnitine acetyltransferase is soluble in 
peroxisomes and membrane bound in mi- 
crosomes, it has been postulated from the 
similarities in properties that the same 
enzyme exists in both these organelles (35). 
The presence of the same enzyme in per- 
oxisomes and in endoplasmic reticulum 
raises some interesting questions regard- 
ing the biogenesis of this protein. From 
morphological evidence it was assumed 
that peroxisomes originate by budding 
off from endoplasmic reticulum (36, 37). 
However, in recent years Lazarow and 
co-workers in an extensive series of in- 
vestigations provided evidence that the 
peroxisomal soluble and membrane-bound 
proteins are biosynthesized on the poly- 
somes in cytosol and then are transferred 
to the peroxisomes (38, 39). It is possible 
that the acyl/alkyl DHAP reductase, syn- 
thesized in cytosol, is transported to both 
the peroxisomes and endoplasmic reticu- 
lum. The equal rate of induction of this en- 
zyme in peroxisomes and microsomes after 
clofibrate feeding supports this hypothesis. 
In Zellweger cerebrohepatorenal syndrome 
where peroxisomes are absent, all of the 
reductase is probably transported to the 
endoplasmic reticulum, thus resulting in 
the normal activity (10). However, it is 
possible that the enzyme present in these 
two cellular compartments may not be ex- 
actly identical and minor differences exist 
between them so that these end up in the 
respective organelles. Only purifying the 
enzymes to homogeneity from these two 
different organelles and comparing their 
properties will clearly establish whether 
or not the same enzyme is present in per- 
oxisomes and microsomes. Present work in 
this laboratory is directed toward this goal 
of purifying the acyl/alkyl DHAP reduc- 
tase solubilized from peroxisomal and mi- 
crosomal membranes. 
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